Dublin, Feb. 13, 2020 (GLOBE NEWSWIRE) -- The "Androgenetic Alopecia - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. Androgenetic Alopecia Pipeline ...

Antibodies targeting the CXCL12 protein show potential to promote hair growth in conditions like androgenic alopecia (AGA) and alopecia areata (AA), offering hope for new treatment options. CXCL12 ...

If you’re reading this because you’re losing your hair, you’re not alone — hair loss is a common issue affecting more than half of men by the time they’re in their forties. The most common type of ...

Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia December 11, 2025 10:00 AM ESTCompany ...

SUWON, South Korea--(BUSINESS WIRE)--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced today that it has received approval from the Human Research Ethics ...

Clascoterone 5%, a topical anti-androgen drug indicated for male pattern hair loss, demonstrated significant hair regrowth ...

Androgenetic alopecia is a common form of hair loss in both women and men. Those with androgenetic alopecia may experience regrowth of hair, but the rate of regrowth is different for everyone.

Researchers at the San Carlos Clinical Hospital in Madrid may have targeted a potential solution for hair loss. A recent study analyzed the effect of injecting mice's skin with stem cells from human ...

SUWON, South Korea--(BUSINESS WIRE)--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced today that the first patient has been administered on June 5, in a ...

Hair loss is a widespread issue, often causing significant distress. While some embrace baldness as "the new sexy," many ...

If you’re reading this because you’re losing your hair, you’re not alone — hair loss is a common issue affecting more than half of men by the time they’re in their forties. The most common type of ...